Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications

MLA

Umar Mehraj, et al. “Chemokines in Triple-Negative Breast Cancer Heterogeneity: New Challenges for Clinical Implications.” Seminars in Cancer Biology, vol. 86, no. Pt 2, Dec. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b9aa54dd5963919a66262b69d205a9fd&authtype=sso&custid=ns315887.

APA

Umar Mehraj, Umar Mushtaq, Manzoor A. Mir, Afnan Saleem, Muzafar A. Macha, Mohammad Nadeem Lone, Abid Hamid, Mohammed A. Zargar, Syed Mudasir Ahmad, & Nissar Ahmad Wani. (2021). Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications. Seminars in Cancer Biology, 86(Pt 2).

Chicago

Umar Mehraj, Umar Mushtaq, Manzoor A. Mir, Afnan Saleem, Muzafar A. Macha, Mohammad Nadeem Lone, Abid Hamid, Mohammed A. Zargar, Syed Mudasir Ahmad, and Nissar Ahmad Wani. 2021. “Chemokines in Triple-Negative Breast Cancer Heterogeneity: New Challenges for Clinical Implications.” Seminars in Cancer Biology 86 (Pt 2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b9aa54dd5963919a66262b69d205a9fd&authtype=sso&custid=ns315887.